Presentations

Presentations

Sep 17, 2019

2019 European Association for the Study of Diabetes (EASD) Presentation

Jul 31, 2019

CRISPR Therapeutics Corporate Presentation

May 02, 2019

2018 AR LOGO

May 02, 2019

2019 Proxy Statement

May 02, 2019

2018 Annual Report

May 01, 2019

2019 ASGCT Annual Meeting Poster: CRISPR/Cas9 Gene Editing to Produce Multiple Allogeneic CAR-T Cell Candidates Showing Consistently High Potency, Durability, Lack of Alloreactivity, and Ability to Overcome Immune Suppression

Apr 05, 2019

2018 PFIC Annual Information Statement

Apr 02, 2019

2019 American Association for Cancer Research (AACR) Annual Meeting Poster: Targeting multiple solid tumor types with anti-CD70 allogeneic CAR-T cells

Apr 01, 2019

2019 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic CRISPR/Cas9 Gene-edited CAR-T Cells Targeting CD33 Show Potent Preclinical Activity Against AML Cells

Dec 01, 2018

2018 Annual Meeting of The American Society of Hematology (ASH) Poster: Preclinical Development of CTX120, an Allogeneic CAR-T Cell Product Candidate Targeting BCMA

Nov 09, 2018

2018 Annual Meeting of The Society for Immunotherapy of Cancer (SITC) Poster: CRISPR/Cas9 Enables the Efficient Production of Allogeneic CAR-T Cells Engineered to Contain Multiple Genome Edits to Enhance Therapeutic T Cell Function

Oct 24, 2018

2017 Annual Report

Aug 02, 2018

CRISPR Therapeutics Corporate Presentation

Jun 13, 2018

Website Version of CRISPR Code of Business Conduct and Ethics (May 2018)

Jun 08, 2018

CRISPR Tx Corp Overview 060818

May 18, 2018

2018 American Society of Gene & Cell Therapy (ASGCT) Poster

May 15, 2018

2018 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Poster: Allogeneic CAR-T Cells with Multiple Therapeutically Favorable Edits Can Be Created Efficiently Using CRISPR/Cas9

May 14, 2018

CRISPR Therapeutics May 2018 Corporate Overview

May 08, 2018

Deutsche Bank 43rd Annual Healthcare Conference

Apr 16, 2018

2018 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic CRISPR Engineered Anti-CD70 CAR-T Cells Demonstrate Potent Preclinical Activity Against Both Solid and Hematological Cancer Cells

Apr 16, 2018

2018 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen

Mar 20, 2018

CRISPR Corporate Overview March 2018

Mar 08, 2018

Articles of Association

Mar 05, 2018

2017 PFIC

Feb 02, 2018

CRISPR Therapeutics Corporate Overview - February 2018

Dec 18, 2017

CRISPR Therapeutics Corporate Overview December 2017

Nov 16, 2017

CRISPR Therapeutics Corporate Overview - November 2017

Nov 07, 2017

20170531 Articles of Association CRISPR Therapeutics AG post AGM

May 24, 2017

2017-05-24 CRISPR Therapeutics Corporate Overview vFINAL

Apr 19, 2017

2016 PFIC Annual Information Statement (FE) (4)

Apr 19, 2017

CRISPR Annual Report

Apr 19, 2017

CRISPR PROXY_bmk

Apr 12, 2017

2016 Annual Report

Feb 03, 2017

Organizational Rules

Feb 03, 2017

2016 PFIC Annual Information Statement (FE)

Jan 31, 2017

Feb 2017 CRISPR Therapeutics Corporate Overview_vF

Jan 31, 2017

CRISPR_Jan 2017 Therapeutics Corporate Overview_vF.pdf

Jan 30, 2017

Jan 2017 CRISPR Therapeutics Corporate Overview_vF.PDF

Dec 27, 2016

Organizational Rules (3 committees) (final)

Dec 27, 2016

Compensation Committee Charter (Split)

Dec 27, 2016

Nominating and Corporate Governance Committee Charter (as approved .12.06.16)

Nov 29, 2016

AoA CRISPR Therapeutics AG

Oct 21, 2016

Code of Business Conduct and Ethics

Oct 21, 2016

Corporate Governance Guidelines

Oct 10, 2016

Audit Committee

Oct 10, 2016

CRISPR - Compensation, Nomination and Corporate Governance Committee

Jul 11, 2016

1130 CRISPR - INTELLIA CRISPR TX POSITION STATEMENT